Role of Tumor Microenvironment in Pituitary Neuroendocrine Tumors: New Approaches in Classification, Diagnosis and Therapy
Cancers · 06.11.2023 · 15 (21) · 5301
DOI: 10.3390/cancers15215301 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 06.11.2023. Verfasst von Dana Antonia Tapoi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Adenohypophysal pituitary tumors account for 10–15% of all intracranial tumors, and 25–55% display signs of invasiveness. Nevertheless, oncology still relies on histopathological examination to establish the diagnosis. Considering that the classification of pituitary tumors has changed significantly in recent years, we discuss the definition of aggressive and invasive tumors and the latest molecular criteria used for classifying these entities. The pituitary tumor microenvironment (TME) is essential for neoplastic development and progression. This review aims to reveal the impact of TME characteristics on stratifying these tumors in view of finding appropriate therapeutic approaches. The role of the pituitary tumor microenvironment and its main components, non-tumoral cells and soluble factors, has been addressed. The variable display of different immune cell types, tumor-associated fibroblasts, and folliculostellate cells is discussed in relation to tumor development and aggressiveness. The molecules secreted by both tumoral and non-tumoral cells, such as VEGF, FGF, EGF, IL6, TNFα, and immune checkpoint molecules, contribute to the crosstalk between the tumor and its microenvironment. They could be considered potential biomarkers for diagnosis and the invasiveness of these tumors, together with emerging non-coding RNA molecules. Therefore, assessing this complex network associated with pituitary neuroendocrine tumors could bring a new era in diagnosing and treating this pathology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Department of Pathology, University Emergency Hospital, 050098 Bucharest, Romania.
- Department of Cellular and Molecular Biology and Histology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Victor Babes National Institute of Pathology, 050096 Bucharest, Romania.
- Department of Cell Biology and Clinical Biochemistry, Faculty of Medicine, Titu Maiorescu University, 031593 Bucharest, Romania.
- Department of Pediatrics, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
ORCID-Profile: Dana Antonia Tapoi, Cristiana Tanase
Zitieren
APA
Tapoi, D. A., Popa, M. L., Tanase, C., Derewicz, D., & Gheorghișan-Gălățeanu, A. A. (2023). Role of Tumor Microenvironment in Pituitary Neuroendocrine Tumors: New Approaches in Classification, Diagnosis and Therapy. Cancers, 15(21), 5301. https://doi.org/10.3390/cancers15215301
Vancouver
Tapoi DA, Popa ML, Tanase C, Derewicz D, Gheorghișan-Gălățeanu AA. Role of Tumor Microenvironment in Pituitary Neuroendocrine Tumors: New Approaches in Classification, Diagnosis and Therapy. Cancers. 2023;15(21):5301. doi:10.3390/cancers15215301
BibTeX
@article{Tapoi2023,
author = {Tapoi, Dana Antonia and Popa, Maria-Linda and Tanase, Cristiana and Derewicz, Diana and Gheorghișan-Gălățeanu, Ancuța-Augustina},
title = {Role of Tumor Microenvironment in Pituitary Neuroendocrine Tumors: New Approaches in Classification, Diagnosis and Therapy},
journal = {Cancers},
year = {2023},
volume = {15},
number = {21},
pages = {5301},
doi = {10.3390/cancers15215301}
}
EUVIMED